PubRank

Martin Stahl

Author PubWeight™ 37.43‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A medicinal chemist's guide to molecular interactions. J Med Chem 2010 3.39
2 Fluorine in medicinal chemistry. Chembiochem 2004 3.25
3 Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis. J Chem Inf Model 2008 2.04
4 Validation and use of the MM-PBSA approach for drug discovery. J Med Chem 2005 1.90
5 Intramolecular hydrogen bonding in medicinal chemistry. J Med Chem 2010 1.75
6 Multiscale contrast enhancement for radiographies: Laplacian Pyramid versus fast wavelet transform. IEEE Trans Med Imaging 2002 1.24
7 Binding site characteristics in structure-based virtual screening: evaluation of current docking tools. J Mol Model 2003 1.20
8 An automated system for the analysis of G protein-coupled receptor transmembrane binding pockets: alignment, receptor-based pharmacophores, and their application. J Chem Inf Model 2005 1.09
9 Chemical fragment spaces for de novo design. J Chem Inf Model 2007 1.04
10 Recore: a fast and versatile method for scaffold hopping based on small molecule crystal structure conformations. J Chem Inf Model 2007 1.03
11 SIGIRR, a negative regulator of TLR/IL-1R signalling promotes Microbiota dependent resistance to colonization by enteric bacterial pathogens. PLoS Pathog 2013 1.02
12 Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screening. J Med Chem 2003 0.99
13 Comparison of the binding pockets of two chemically unrelated allosteric antagonists of the mGlu5 receptor and identification of crucial residues involved in the inverse agonism of MPEP. J Neurochem 2006 0.98
14 Prediction of pKa shifts in proteins using a combination of molecular mechanical and continuum solvent calculations. J Comput Chem 2004 0.98
15 Rationalizing tight ligand binding through cooperative interaction networks. J Chem Inf Model 2011 0.95
16 Design of novel aminopyrrolidine factor Xa inhibitors from a screening hit. Eur J Med Chem 2009 0.94
17 Oxidosqualene cyclase second-sphere residues profoundly influence the product profile. Chembiochem 2004 0.91
18 Tyramine fragment binding to BACE-1. Bioorg Med Chem Lett 2008 0.88
19 Focused library design in GPCR projects on the example of 5-HT(2c) agonists: comparison of structure-based virtual screening with ligand-based search methods. Proteins 2005 0.88
20 Phenotypic screening of a targeted mutant library reveals Campylobacter jejuni defenses against oxidative stress. Infect Immun 2014 0.85
21 CONFECT: conformations from an expert collection of torsion patterns. ChemMedChem 2013 0.84
22 From astemizole to a novel hit series of small-molecule somatostatin 5 receptor antagonists via GPCR affinity profiling. J Med Chem 2007 0.83
23 Dose-dependent antithrombotic activity of an orally active tissue factor/factor VIIa inhibitor without concomitant enhancement of bleeding propensity. Bioorg Med Chem 2006 0.82
24 Torsion angle preferences in druglike chemical space: a comprehensive guide. J Med Chem 2013 0.80
25 Discovery of a factor Xa inhibitor (3R,4R)-1-(2,2-difluoro-ethyl)-pyrrolidine-3,4-dicarboxylic acid 3-[(5-chloro-pyridin-2-yl)-amide] 4-[[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide] as a clinical candidate. Bioorg Med Chem Lett 2010 0.80
26 The Serine Protease Autotransporter Pic Modulates Citrobacter rodentium Pathogenesis and Its Innate Recognition by the Host. Infect Immun 2015 0.79
27 Design of libraries targeting protein-protein interfaces. ChemMedChem 2013 0.79
28 Insights into the mode of action of benzyl isothiocyanate on Campylobacter jejuni. Appl Environ Microbiol 2013 0.79
29 The environment of amide groups in protein-ligand complexes: H-bonds and beyond. J Mol Model 2005 0.78
30 Ensemble methods for classification in cheminformatics. J Chem Inf Comput Sci 2004 0.78
31 Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors. Bioorg Med Chem Lett 2005 0.78
32 3-Amino-pyrazolo[3,4-d]pyrimidines as p38α kinase inhibitors: design and development to a highly selective lead. Bioorg Med Chem Lett 2011 0.77
33 Discovery of 6-(2,4-difluorophenoxy)-2-[3-hydroxy-1-(2-hydroxyethyl)propylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one (pamapimod) and 6-(2,4-difluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (R1487) as orally bioavailable and highly selective inhibitors of p38α mitogen-activated protein kinase. J Med Chem 2011 0.76
34 Computational medicinal chemistry. J Med Chem 2010 0.75
35 Mechanistic insights into oxidosqualene cyclizations through homology modeling. J Comput Chem 2003 0.75
36 Prediction of UV and ESI-MS signal intensities. J Chem Inf Model 2005 0.75